* Japanese*
Asahikawa Medical College , Faculty of Medicine
2007.03 , Graduated
Asahikawa Medical College , Graduate School, Division of Medical Sciences
Doctor Course , 2014.03 , Completed
Duty , Asahikawa Medical University School of Medicine Medical Course Clinical Medicine - , Assistant Professor , 2019.01 -
Duty , Asahikawa Medical University Endowed Chair - , Research Assistant , 2017.04 - 2018.12
Concurrently , Asahikawa Medical University Graduate School Medical Related Research Doctor Course Medicine , Graduate Student , 2010.04 - 2014.03
Gastroenterology
English: Kunogi T, Konishi H, Sakatani A, Moriichi K, Yamamura C, Yamamoto K, Kashima S, Ando K, Ueno N, Tanaka H, Okumura T, Fujiya M., Probiotic-derived ferrichrome induces DDIT3-mediated antitumor effects in esophageal cancer cells. , Heliyon. , vol.10 (6) (p.e28070 - ) , 2024
English: Moriichi K, Kashima S, Kobayashi Y, Sugiyama Y, Murakami Y, Sasaki T, Kunogi T, Takahashi K, Ando K, Ueno N, Tanabe H, Date A, Yuzawa S, Fujiya M., Cardiac sarcoidosis in a patient with ulcerative colitis: A case report and literature review. , Medicine (Baltimore). , vol.103 (1) (p.e36207 - ) , 2024
English: Ueno N, Saito S, Sato M, Sugiyama Y, Kobayashi Y, Murakami Y, Sugimura K, Sasaki T, Sakatani A, Takahashi K, Tanaka K, Serikawa S, Ando K, Kashima S, Muto M, Inaba Y, Moriichi K, Tanabe H, Okumura T, Fujiya M., The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study. , Ther Apher Dial. , 2024
English: Sakurai T, Omori T, Tanaka H, Ito T, Ando K, Yamamura T, Nanjjo S, Osawa S, Takeda T, Watanabe K, Hiraga H, Yamamoto S, Ozeki K, Tanaka S, Tajiri H, Saruta M; SPREAD-J group., Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn's disease in Japan (SPREAD-J study). , J Gastroenterol. , vol.58 (10) (p.1003 - 1014) , 2023
English: Kazama T, Ando K, Ueno N, Fujiya M, Ito T, Maemoto A, Ishigami K, Nojima M, Nakase H., Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study. , PLoS One. , vol.18 (9) (p.e0288393 - ) , 2023
Partner division:Private Enterprise , 2021.11 - 2022.07
2021year , Representative , 2,076,923yen
2022year , Representative , 1,661,539yen
Partner division:Private Enterprise , 2023.08 - 2024.03
2023year , Representative , 500,000yen
Partner division:Private Enterprise , 2022.08 - 2023.03
2022year , Representative , 300,000yen
Updated on 2024/04/04
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.